Literature DB >> 9495261

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

L Kilander, H Nyman, M Boberg, L Hansson, H Lithell.   

Abstract

Recent findings of a linkage between high blood pressure (BP) and later development of dementia have given new prospects on cerebral target-organ damage in hypertension and have added substance to the concept of "preventable senility." The aim of this study was to analyze the impact of hypertension, circadian BP profile, and disturbed glucose metabolism on cognitive function. The study population consisted of 999 seventy-year-old men from a population-based cohort study in Uppsala, Sweden, followed with respect to cardiovascular risk factors since the age of 50 years. At the age of 70, 24-hour ambulatory BP was monitored together with measurements of insulin sensitivity, glucose tolerance, serum lipids, and lipoproteins. Cognitive function was assessed by the Mini-Mental State Examination and the Trail-Making Test. High diastolic BP at baseline predicted later impaired cognitive performance, even after excluding men with a previous stroke (n = 70). Cross-sectional measurements at age 70 showed that high 24-hour BP, nondipping, insulin resistance, and diabetes all were related to low cognitive function. The relationships between hypertension and cognitive impairment were strongest in untreated men. These data from a general population of healthy elderly men indicate that hypertension and associated metabolic disturbances might be susceptibility factors for cognitive disorders. The findings add support to possibilities of intervention in early stages in cognitive decline, ie, before manifest dementia.

Entities:  

Mesh:

Year:  1998        PMID: 9495261     DOI: 10.1161/01.hyp.31.3.780

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  153 in total

Review 1.  Does the angiotensin II receptor antagonist losartan improve cognitive function?

Authors:  Michele A Tedesco; Gennaro Ratti; Giovanni Di Salvo; Francesco Natale
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 2.  Protection against stroke and dementia: an update on the latest clinical trial evidence.

Authors:  Bryan Williams
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 3.  [Arterial hypertension and dementia].

Authors:  R Scheid; H Voigt
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

4.  Association between white matter microstructure, executive functions, and processing speed in older adults: the impact of vascular health.

Authors:  Heidi I L Jacobs; Elizabeth C Leritz; Victoria J Williams; Martin P J Van Boxtel; Wim van der Elst; Jelle Jolles; Frans R J Verhey; Regina E McGlinchey; William P Milberg; David H Salat
Journal:  Hum Brain Mapp       Date:  2011-09-23       Impact factor: 5.038

5.  The process-knowledge model of health literacy: evidence from a componential analysis of two commonly used measures.

Authors:  Jessie Chin; Daniel G Morrow; Elizabeth A L Stine-Morrow; Thembi Conner-Garcia; James F Graumlich; Michael D Murray
Journal:  J Health Commun       Date:  2011

6.  Midlife cardiovascular risk impacts executive function: Framingham offspring study.

Authors:  Arvind Nishtala; Sarah R Preis; Alexa Beiser; Sherral Devine; Lisa Hankee; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

7.  Neuromarkers of the common angiotensinogen polymorphism in healthy older adults: A comprehensive assessment of white matter integrity and cognition.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Yi Zhao; Xi Luo; Youdan Wang; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; David F Tate; Erbil Akbudak; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Lee M Cagle; Robert H Paul
Journal:  Behav Brain Res       Date:  2015-08-28       Impact factor: 3.332

Review 8.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

Review 9.  Effect of antihypertensive agents on quality of life in the elderly.

Authors:  Roberto Fogari; Annalisa Zoppi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Cognition and health literacy in patients with hypertension.

Authors:  Brian R Levinthal; Daniel G Morrow; Wanzhu Tu; Jingwei Wu; Michael D Murray
Journal:  J Gen Intern Med       Date:  2008-05-06       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.